Abstract
Research into ageing and its underlying molecular basis enables us to develop and implement targeted interventions to ameliorate or cure its consequences. However, the efficacy of interventions often differs widely between individuals, suggesting that populations should be stratified or even individualized. Large-scale cohort studies in humans, similar systematic studies in model organisms as well as detailed investigations into the biology of ageing can provide individual validated biomarkers and mechanisms, leading to recommendations for targeted interventions. Human cohort studies are already ongoing, and they can be supplemented by in silico simulations. Systematic studies in animal models are made possible by the use of inbred strains or genetic reference populations of mice. Combining the two, a comprehensive picture of the various determinants of ageing and ‘health span' can be studied in detail, and an appreciation of the relevance of results from model organisms to humans is emerging. The interactions between genotype and environment, particularly the psychosocial environment, are poorly studied in both humans and model organisms, presenting serious challenges to any approach to a personalized medicine of ageing. To increase the success of preventive interventions, we argue that there is a pressing need for an individualized evaluation of interventions such as physical exercise, nutrition, nutraceuticals and calorie restriction mimetics as well as psychosocial and environmental factors, separately and in combination. The expected extension of the health span enables us to refocus health care spending on individual prevention, starting in late adulthood, and on the brief period of morbidity at very old age.
References
1.
Olshansky SJ, Carnes BA, Cassel C: In search of Methuselah: estimating the upper limits to human longevity. Science 1990;250:634-640.
2.
Niccoli T, Partridge L: Ageing as a risk factor for disease. Curr Biol 2012;22:R741-R752.
3.
Partridge L: Intervening in ageing to prevent the diseases of ageing. Trends Endocrinol Metab 2014;25:555-557.
4.
Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G: The hallmarks of aging. Cell 2013;153:1194-1217.
5.
Baker GT 3rd, Sprott RL: Biomarkers of aging. Exp Gerontol 1988;23:223-239.
6.
Johnson TE: Recent results: biomarkers of aging. Exp Gerontol 2006;41:1243-1246.
7.
Simm A, Nass N, Bartling B, Hofmann B, Silber RE, Navarrete Santos A: Potential biomarkers of ageing. Biol Chem 2008;389:257-265.
8.
Moeller M, Hirose M, Mueller S, Roolf C, Baltrusch S, Ibrahim S, Junghanss C, Wolkenhauer O, Jaster R, Köhling R, Kunz M, Tiedge M, Schofield PN, Fuellen G: Inbred mouse strains reveal biomarkers that are pro-longevity, antilongevity or role switching. Aging Cell 2014;13:729-738.
9.
Martin-Ruiz C, von Zglinicki T: Biomarkers of healthy ageing: expectations and validation. Proc Nutr Soc 2014;73:422-429.
10.
Lagaay AM, van Asperen IA, Hijmans W: The prevalence of morbidity in the oldest old, aged 85 and over: a population-based survey in Leiden, The Netherlands. Arch Gerontol Geriatr 1992;15:115-131.
11.
Collerton J, Barrass K, Bond J, Eccles M, Jagger C, James O, Martin-Ruiz C, Robinson L, von Zglinicki T, Kirkwood T: The Newcastle 85+ Study: biological, clinical and psychosocial factors associated with healthy ageing: study protocol. BMC Geriatr 2007;7:14.
12.
Lara J, Cooper R, Nissan J, Ginty AT, Khaw KT, Deary IJ, Lord JM, Kuh D, Mathers JC: A proposed panel of biomarkers of healthy ageing. BMC Med 2015;13:222.
13.
Dall'Olio F, Vanhooren V, Chen CC, Slagboom PE, Wuhrer M, Franceschi C: N-glycomic biomarkers of biological aging and longevity: a link with inflammaging. Ageing Res Rev 2013;12:685-698.
14.
van Peet PG, de Craen AJ, Gussekloo J, de Ruijter W: Plasma NT-proBNP as predictor of change in functional status, cardiovascular morbidity and mortality in the oldest old: the Leiden 85-plus Study. Age (Dordr) 2014;36:9660.
15.
Horvath S: DNA methylation age of human tissues and cell types. Genome Biol 2013;14:R115.
16.
Weidner CI, Lin Q, Koch CM, Eisele L, Beier F, Ziegler P, Bauerschlag DO, Jöckel KH, Erbel R, Mühleisen TW, Zenke M, Brümmendorf TH, Wagner W: Aging of blood can be tracked by DNA methylation changes at just three CpG sites. Genome Biol 2014;15:R24.
17.
Hamburg MA, Collins FS: The path to personalized medicine. N Engl J Med 2010;363:301-304.
18.
Snyder M: iPOP and its role in participatory medicine. Genome Med 2014;6:6.
19.
McEwen BS, Getz L: Lifetime experiences, the brain and personalized medicine: an integrative perspective. Metabolism 2013;62(suppl 1):S20-S26.
20.
Mahmood SS, Levy D, Vasan RS, Wang TJ: The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet 2014;383:999-1008.
21.
Völzke H, Alte D, Schmidt CO, et al: Cohort profile: the study of health in Pomerania. Int J Epidemiol 2011;40:294-307.
22.
Wichmann HE, Kaaks R, Hoffmann W, Jöckel KH, Greiser KH, Linseisen J: The German National Cohort (in German). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2012;55:781-787.
23.
Gems D, Partridge L: Genetics of longevity in model organisms: debates and paradigm shifts. Annu Rev Physiol 2013;75:621-644.
24.
Behrens A, van Deursen JM, Rudolph KL, Schumacher B: Impact of genomic damage and ageing on stem cell function. Nat Cell Biol 2014;16:201-207.
25.
Kirkland JL: Translating advances from the basic biology of aging into clinical application. Exp Gerontol 2013;48:1-5.
26.
Colman RJ, Anderson RM, Johnson SC, Kastman EK, Kosmatka KJ, Beasley TM, Allison DB, Cruzen C, Simmons HA, Kemnitz JW, Weindruch R: Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 2009;325:201-204.
27.
Mattison JA, Roth GS, Beasley TM, Tilmont EM, Handy AM, Herbert RL, Longo DL, Allison DB, Young JE, Bryant M, Barnard D, Ward WF, Qi W, Ingram DK, de Cabo R: Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study. Nature 2012;489:318-321.
28.
Nebel A, Kleindorp R, Caliebe A, Nothnagel M, Blanché H, Junge O, Wittig M, Ellinghaus D, Flachsbart F, Wichmann HE, Meitinger T, Nikolaus S, Franke A, Krawczak M, Lathrop M, Schreiber S: A genome-wide association study confirms APOE as the major gene influencing survival in long-lived individuals. Mech Ageing Dev 2011;132:324-330.
29.
Yuan R, Peters LL, Paigen B: Mice as a mammalian model for research on the genetics of aging. ILAR J 2011;52:4-15.
30.
Bartke A: Single-gene mutations and healthy ageing in mammals. Philos Trans R Soc Lond B Biol Sci 2011;366:28-34.
31.
Miller RA, Harrison DE, Astle CM, Floyd RA, Flurkey K, Hensley KL, Javors MA, Leeuwenburgh C, Nelson JF, Ongini E, Nadon NL, Warner HR, Strong R: An Aging Interventions Testing Program: study design and interim report. Aging Cell 2007;6:565-575.
32.
Johnson SC, Rabinovitch PS, Kaeberlein M: mTOR is a key modulator of ageing and age-related disease. Nature 2013;493:338-345.
33.
Martin-Montalvo A, Mercken EM, Mitchell SJ, Palacios HH, Mote PL, Scheibye-Knudsen M, Gomes AP, Ward TM, Minor RK, Blouin MJ, Schwab M, Pollak M, Zhang Y, Yu Y, Becker KG, Bohr VA, Ingram DK, Sinclair DA, Wolf NS, Spindler SR, Bernier M, de Cabo R: Metformin improves healthspan and lifespan in mice. Nat Commun 2013;4:2192.
34.
Liao CY, Johnson TE, Nelson JF: Genetic variation in responses to dietary restriction - an unbiased tool for hypothesis testing. Exp Gerontol 2013;48:1025-1029.
35.
Miller RA, Harrison DE, Astle CM, Baur JA, Boyd AR, de Cabo R, Fernandez E, Flurkey K, Javors MA, Nelson JF, Orihuela CJ, Pletcher S, Sharp ZD, Sinclair D, Starnes JW, Wilkinson JE, Nadon NL, Strong R: Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci 2011;66:191-201.
36.
Kyrø C, Olsen A, Landberg R, et al: Plasma alkylresorcinols, biomarkers of whole-grain wheat and rye intake, and incidence of colorectal cancer. J Natl Cancer Inst 2014;106:djt352.
37.
Gardener SL, Rainey-Smith SR, Barnes MB, Sohrabi HR, Weinborn M, Lim YY, Harrington K, Taddei K, Gu Y, Rembach A, Szoeke C, Ellis KA, Masters CL, Macaulay SL, Rowe CC, Ames D, Keogh JB, Scarmeas N, Martins RN: Dietary patterns and cognitive decline in an Australian study of ageing. Mol Psychiatry 2015;20:860-866.
38.
Collerton J, Martin-Ruiz C, Kenny A, Barrass K, von Zglinicki T, Kirkwood T, Keavney B: Telomere length is associated with left ventricular function in the oldest old: the Newcastle 85+ Study. Eur Heart J 2007;28:172-176.
39.
Bertram L, Böckenhoff A, Demuth I, Düzel S, Eckardt R, Li SC, Lindenberger U, Pawelec G, Siedler T, Wagner GG, Steinhagen-Thiessen E: Cohort profile: the Berlin Aging Study II (BASE-II). Int J Epidemiol 2014;43:703-712.
40.
Yuan R, Meng Q, Nautiyal J, Flurkey K, Tsaih SW, Krier R, Parker MG, Harrison DE, Paigen B: Genetic coregulation of age of female sexual maturation and lifespan through circulating IGF1 among inbred mouse strains. Proc Natl Acad Sci USA 2012;109:8224-8229.
41.
Bogue MA, Peters LL, Paigen B, Korstanje R, Yuan R, Ackert-Bicknell C, Grubb SC, Churchill GA, Chesler EJ: Accessing data resources in the mouse phenome database for genetic analysis of murine life span and health span. J Gerontol A Biol Sci Med Sci 2014, Epub ahead of print.
42.
Threadgill DW, Churchill GA: Ten years of the Collaborative Cross. G3 (Bethesda) 2012;2:153-156.
43.
Nithianantharajah J, Hannan AJ: The neurobiology of brain and cognitive reserve: mental and physical activity as modulators of brain disorders. Prog Neurobiol 2009;89:369-382.
44.
Tosto G, Reitz C: Genome-wide association studies in Alzheimer's disease: a review. Curr Neurol Neurosci Rep 2013;13:381.
45.
Lewejohann L, Reefmann N, Widmann P, Ambree O, Herring A, Keyvani K, Paulus W, Sachser N: Transgenic Alzheimer mice in a semi-naturalistic environment: more plaques, yet not compromised in daily life. Behav Brain Res 2009;201:99-102.
46.
Barnum CJ, Pace TW, Hu F, Neigh GN, Tansey MG: Psychological stress in adolescent and adult mice increases neuroinflammation and attenuates the response to LPS challenge. J Neuroinflammation 2012;9:9.
47.
Grady DL, Thanos PK, Corrada MM, Barnett JC Jr, Ciobanu V, Shustarovich D, Napoli A, Moyzis AG, Grandy D, Rubinstein M, Wang GJ, Kawas CH, Chen C, Dong Q, Wang E, Volkow ND, Moyzis RK: DRD4 genotype predicts longevity in mouse and human. J Neurosci 2013;33:286-291.
48.
Kienhuis AS, van de Poll MC, Wortelboer H, van Herwijnen M, Gottschalk R, Dejong CH, Boorsma A, Paules RS, Kleinjans JC, Stierum RH, van Delft JH: Parallelogram approach using rat-human in vitro and rat in vivo toxicogenomics predicts acetaminophen-induced hepatotoxicity in humans. Toxicol Sci 2009;107:544-552.
49.
Hoehndorf R, Hiebert T, Hardy NW, Schofield PN, Gkoutos GV, Dumontier M: Mouse model phenotypes provide information about human drug targets. Bioinformatics 2014;30:719-725.
50.
Machado CM, Rebholz-Schuhmann D, Freitas AT, Couto FM: The semantic web in translational medicine: current applications and future directions. Brief Bioinform 2015;16:89-103.
51.
Kriete A, Lechner M, Clearfield D, Bohmann D: Computational systems biology of aging. Wiley Interdiscip Rev Syst Biol Med 2011;3:414-428.
52.
Pon JR, Marra MA: Driver and passenger mutations in cancer. Annu Rev Pathol 2015;10:25-50.
53.
Sundberg JP, Berndt A, Sundberg BA, Silva KA, Kennedy V, Bronson R, Yuan R, Paigen B, Harrison D, Schofield PN: The mouse as a model for understanding chronic diseases of aging: the histopathologic basis of aging in inbred mice. Pathobiol Aging Age Relat Dis 2011;1:10.3402/pba.v1i0.7179.
54.
Johnson SC, Dong X, Vijg J, Suh Y: Genetic evidence for common pathways in human age-related diseases. Aging Cell 2015;14:809-817.
55.
Cen W, Freitas AA, de Magalhaes JP: Predicting the pro-longevity or anti-longevity effect of model organism genes with new hierarchical feature selection methods. IEEE/ACM Trans Comput Biol Bioinform 2015;12:262-275.
56.
Callahan A, Cifuentes JJ, Dumontier M: An evidence-based approach to identify aging-related genes in Caenorhabditis elegans. BMC Bioinformatics 2015;16:40.
57.
Anlasik T, Sies H, Griffiths HR, Mecocci P, Stahl W, Polidori MC: Dietary habits are major determinants of the plasma antioxidant status in healthy elderly subjects. Br J Nutr 2005;94:639-642.
58.
Polidori MC, Praticó D, Mangialasche F, Mariani E, Aust O, Anlasik T, Mang N, Pientka L, Stahl W, Sies H, Mecocci P, Nelles G: High fruit and vegetable intake is positively correlated with antioxidant status and cognitive performance in healthy subjects. J Alzheimers Dis 2009;17:921-927.
59.
Polidori MC, Carrillo JC, Verde PE, Sies H, Siegrist J, Stahl W: Plasma micronutrient status is improved after a 3-month dietary intervention with 5 daily portions of fruits and vegetables: implications for optimal antioxidant levels. Nutr J 2009;8:10.
60.
Mecocci P, Tinarelli C, Schulz RJ, Polidori MC: Nutraceuticals in cognitive impairment and Alzheimer's disease. Frontiers Pharmacol 2014;5:147.
61.
Polidori MC, Schulz RJ: Nutritional contributions to dementia prevention: main issues on antioxidant micronutrients. Genes Nutr 2014;92:382.
62.
Wald DS, Morris JK, Wald NJ: Randomized Polypill crossover trial in people aged 50 and over. PLoS One 2012;7:e41297.
63.
Rickman AD, Williamson DA, Martin CK, Gilhooly CH, Stein RI, Bales CW, Roberts S, Das SK: The CALERIE Study: design and methods of an innovative 25% caloric restriction intervention. Contemp Clin Trials 2011;32:874-881.
64.
Andersen SL, Sebastiani P, Dworkis DA, Feldman L, Perls TT: Health span approximates life span among many supercentenarians: compression of morbidity at the approximate limit of life span. J Gerontol A Biol Sci Med Sci 2012;67:395-405.
65.
Goldman DP, Cutler D, Rowe JW, Michaud PC, Sullivan J, Peneva D, Olshansky SJ: Substantial health and economic returns from delayed aging may warrant a new focus for medical research. Health Aff (Millwood) 2013;32:1698-1705.
66.
Olshansky SJ, Perry D, Miller RA, Butler RN: Pursuing the longevity dividend: scientific goals for an aging world. Ann NY Acad Sci 2007;1114:11-13.
67.
Pallauf K, Giller K, Huebbe P, Rimbach G: Nutrition and healthy ageing: calorie restriction or polyphenol-rich ‘MediterrAsian' diet? Oxid Med Cell Longev 2013;2013:707421.
68.
Jerant A, Chapman B, Duberstein P, Robbins J, Franks P: Personality and medication non-adherence among older adults enrolled in a six-year trial. Br J Health Psychol 2011;16:151-169.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
